Peptide COAs
Bpc 157
80 public audits matching your filters. Scores are PeptIQ’s legitimacy model; missing panels lower thoroughness but aren’t automatically “bad” — open a report to see pass, fail, reported, and missing panels clearly.
Public certificates
Approved community and directory-linked COAs only.
- Wolverine + BPC-157 + TB-500
Crush Research · Jul 28, 2026 · 5/7 panels · 99.84% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns95 - BPC-157
Crush Research · Jul 28, 2026 · 5/7 panels · 99.97% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns95 - BPC-157
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.25% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.54% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.26% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.26% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.54% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
American Peptide Research · Jul 29, 2026 · 2/7 panels · 99.25% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Revitalized Research · Jul 29, 2026 · 2/7 panels · 99.42% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - Klow + GHK-Cu + KPV + BPC-157 + TB-500
AMC Essentials · Jul 29, 2026 · 6/7 panels · 99.607% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + TB-500
Virtus Peptides · Jul 29, 2026 · 5/7 panels · 99.89% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Peptide Partners · Jul 29, 2026 · 2/7 panels · 99.823% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Peptide Partners · Jul 29, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Peptide Partners · Jul 29, 2026 · 5/7 panels · 99.746% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + Wolverine
Retalux · Jul 29, 2026 · 2/7 panels · 99.2% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Peptide Partners · Jul 29, 2026 · 2/7 panels · 99.72% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + TB-500 + TB4
Peptide Partners · Jul 29, 2026 · 2/7 panels · 99.735% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - TB-500 + BPC-157 + KPV + GHK-Cu
Peptide Partners · Jul 29, 2026 · 6/7 panels · 99.855% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + GHK-Cu + KPV + Thymosin β4
Pepturion · Jul 29, 2026 · 4/7 panels · 99.9% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + TB-500
Peptide Partners · Jul 29, 2026 · 6/7 panels · 99.9% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - GLOW + GHK-Cu + TB-500-Frg + BPC-157
Lumira · Jul 29, 2026 · 2/7 panels · 99.7% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - GLOW + GHK-Cu + BPC-157 + TB-4
Retalux · Jul 29, 2026 · 2/7 panels · 99.95% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + TB-500
Retalux · Jul 29, 2026 · 2/7 panels · 99.5% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + TB-500
Peptide Partners · Jul 28, 2026 · 2/7 panels · 99.64% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - Limulus Amebocyte Lysate (LAL) + GHK-Cu + BPC-157 + TB500
BioLongevity Labs · Jul 28, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Peptide Partners · Jul 28, 2026 · 2/7 panels · 99.46% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC 157 Arginate Salt + BPC 157
BioLongevity Labs · Jul 28, 2026 · 2/7 panels · 99.48% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - KLOW Blend 80mg + KPV + GHK-Cu + BPC-157 + TB-500
Brand not listed · Jul 28, 2026 · 4/7 panels · 99.9% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - Wolverine Blend + BPC-157 + TB-500
Brand not listed · Jul 28, 2026 · 4/7 panels · 99.9% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Peptide Partners · Jul 28, 2026 · 2/7 panels · 99.992% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + Thymosin Beta-4 + BPC-157/TB-500
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.111% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Blank Peptides · Jul 28, 2026 · 3/7 panels · 99.935% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Crush Research · Jul 28, 2026 · 3/7 panels · 99.7% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - Klow + GHK-Cu + BPC-157 + TB-4 + KPV
Crush Research · Jul 28, 2026 · 5/7 panels · 99.47% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
Crush Research · Jul 28, 2026 · 5/7 panels · 99.86% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - Wolverine + BPC-157 + TB-500
Crush Research · Jul 28, 2026 · 5/7 panels · 99.9% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - GHK-Cu + TB-500 + BPC-157 + KPV
Crush Research · Jul 28, 2026 · 5/7 panels · 99.65% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - KLOW + GHK-Cu + BPC-157 + TB-500 + KPV
Crush Research · Jul 28, 2026 · 5/7 panels · 99.98% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157 + TB-500 + TB-4
Crush Research · Jul 28, 2026 · 5/7 panels · 99.86% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - KLOW + GHK-Cu + BPC-157 + TB-500 + KPV
Crush Research · Jul 28, 2026 · 5/7 panels · 99.52% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
American Peptide Research · Jul 28, 2026 · 2/7 panels · 99.54% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns92 - BPC-157
BioLongevity Labs · Jul 28, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157
BioLongevity Labs · Jul 28, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157
Peptide Partners · Jul 28, 2026 · 2/7 panels · 99.6% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC157 + BPC-157
BioLongevity Labs · Jul 28, 2026 · 2/7 panels · 99.94% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157 + TB-500
Peptide Partners · Jul 28, 2026 · 2/7 panels · 99.65% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157 + TB-500
Peptide Partners · Jul 28, 2026 · 2/7 panels · 99.519% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157 + Thymosin Beta-4 + BPC-157/TB-500
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.01% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - GHK-Cu/BPC-157/TB-500 + GHK-Cu + BPC-157 + Thymosin Beta-4
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.64% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.247% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157
Blank Peptides · Jul 28, 2026 · 2/7 panels · 99.092% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - GHK-Cu + KPV + BPC-157 + Thymosin Beta-4
Crush Research · Jul 28, 2026 · 3/7 panels · 99.78% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157
Crush Research · Jul 28, 2026 · 3/7 panels · 99.69% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns88 - BPC-157 + Thymosin Beta-4 + BPC-157/Thymosin Beta-4 + BPC/TB-500
Amino Tech · Jul 29, 2026 · 2/7 panels · 99.935% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157
American Peptide Research · Jul 29, 2026 · 2/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157
American Peptide Research · Jul 29, 2026 · 2/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157
Paramount Peptides · Jul 29, 2026 · 1/7 panels · 99.608% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157
Paramount Peptides · Jul 29, 2026 · 1/7 panels · 99.4% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157 + Thymosin Beta-4
Retalux · Jul 29, 2026 · 3/7 panels · 99.93% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - GHK-Cu + BPC-157 + Thymosin Beta-4
Pepturion · Jul 29, 2026 · 3/7 panels · 99.84% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157 + BPC 157
Pepturion · Jul 29, 2026 · 3/7 panels · 99.463% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - GHK-Cu + BPC-157 + Thymosin Beta-4
Retalux · Jul 29, 2026 · 2/7 panels · 99.911% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157
Peptide Partners · Jul 29, 2026 · 2/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157
Peptide Partners · Jul 29, 2026 · 1/7 panels
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - BPC-157 + GHK-Cu + KPV + Thymosin β4
Lumira · Jul 29, 2026 · 3/7 panels · 99.5% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - Wolverine + BPC-157 + Thymosin β4
Pepturion · Jul 29, 2026 · 2/7 panels · 99.7% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72 - KLOW + GHK-Cu + KPV + BPC-157 + TB500
Lumira · Jul 29, 2026 · 2/7 panels · 99.5% purity
Several fields check out, but we found issues worth reviewing before you rely on this document.
Mostly consistent, with concerns72
Community-sourced
Help build the COA record
PeptIQ’s market snapshot comes from moderator-approved certificates and curated peptide brands and testing laboratories — not invented stats. Contribute a COA or claim your listing.
Community submissions are reviewed before they appear on public market pages. Private COA scans stay private until you share them.
Brand owners: claim or list your peptide brand, upload COAs tied to it in the app, then track trust scores on your public brand page and the COA market.
Upload a COA
Scan a certificate of analysis in the app. Public shares go through review before the market.
List / claim a peptide brand
Apply to list or claim your vendor profile. Listings stay unpublished until PeptIQ approves them.
Claim / list a testing laboratory
Third-party peptide testing labs (HPLC, endotoxin, etc.) can claim or request a directory presence.
See brand trust & reputation
Browse vendor trust scores and legitimacy from moderator-approved public COAs on the market.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.